Humana (HUM)
(Delayed Data from NYSE)
$260.71 USD
+2.88 (1.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$260.71 USD
+2.88 (1.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Zacks News
Humana (HUM) Surpasses on Q2 Earnings, Raises EPS Guidance
by Zacks Equity Research
Humana's (HUM) Q2 earnings register growth on the back of Medicare Advantage enrollment and solid strategies. The company also lifts its EPS outlook.
WellCare Health Plans (WCG) Jumps: Stock Rises 7.3%
by Zacks Equity Research
WellCare Health Plans (WCG) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Humana (HUM) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 4.49% and 0.71%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Medical Stock Q2 Earnings Due on Aug 1: ESRX, DVA & HUM
by Zacks Equity Research
Solid R&D prospects likely to drive the healthcare industry in Q2 earnings.
What's in the Cards for Humana (HUM) Stock in Q2 Earnings?
by Zacks Equity Research
Humana's (HUM) second quarter is likely to gain traction from solid individual Medicare Advantage membership growth.
Centene (CNC) Beats Q2 Earnings Estimates, Revises Guidance
by Zacks Equity Research
Centene's (CNC) second-quarter earnings beat on revenue and membership growth. The top line improves owing to Health Insurance Marketplace business, acquisitions and expansions.
Why Dip in UnitedHealth Stock Post Q2 is a Good Entry Point
by Zacks Equity Research
Despite concerns over some parts of UnitedHealth's (UNH) Q2 earnings, its long-term growth prospects are bright.
How Will Membership Affect UnitedHealth's (UNH) Q2 Earnings?
by Zacks Equity Research
UnitedHealth (UNH) should see an increase in Public Group and International business, partially offset by lower commercial membership.
Humana (HUM) Jointly Buys Curo, Boosts Medicare Business
by Zacks Equity Research
Humana (HUM) completes its joint acquisition of Curo with WCAS to expand its Medicare Advantage business.
5 Stocks With Domestic Focus to Evade Trade War Fears
by Ritujay Ghosh
Trade war fears have been keeping markets volatile for some time now. So it makes sense to add stocks with domestic focus to your portfolio right away.
4 Reasons That Make WellCare Health Plans an Attractive Pick
by Zacks Equity Research
WellCare Health Plans (WCG) looks attractive given its promising growth prospects.
Humana (HUM) Hits 52-Week High, Is Further Upside Left?
by Zacks Equity Research
Riding high on Kindred Healthcare acquisition and a recent rating affirmation, Humana's (HUM) shares reach a 52-week high on July 6.
Centene (CNC) Hits 52 Week High: Is Further Upside Left?
by Zacks Equity Research
Shares of Centene (CNC) gain on recent deals and its robust growth should drive it further.
WCG Vs. MOH: Which Health Insurance Stock is Better Placed
by Zacks Equity Research
Wellcare and Molina are both poised to grow in a thriving health insurance industry, but one has an edge over the other.
Ensign Boosts Skilled Nursing Facility With McCall Buyout
by Zacks Equity Research
Ensign's (ENSG) acquisition of McCall reflects its strategy to expand in the growing skilled nursing market.
Humana Jointly Acquires Kindred, Expands Into Patient Care
by Zacks Equity Research
Humana (HUM) jointly acquires Kindred to expand its geographical presence.
Centene (CNC) to Tap New York Market Through Fidelis Care
by Zacks Equity Research
Centene (CNC) acquires Fidelis Care for $3.75 billion. This strategic move is likely to help expand the company's footprint across the state of New York.
4 Top Health Insurance Stocks of 1H With Room to Run in 2H
by Sapna Bagaria
Rise in membership, revenue diversification, healthy balance sheet and cost control are behind the strong performance in 1H.
Top Analyst Reports for Pfizer, BHP Billiton & Facebook
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), BHP Billiton (BHP) and Facebook (FB)
Zacks Industry Outlook Highlights: WellCare, Molina, Humana and Anthem
by Zacks Equity Research
Zacks Industry Outlook Highlights: WellCare, Molina, Humana and Anthem
Community Health Arm to Divest AllianceHealth Deaconess
by Zacks Equity Research
Community Health (CYH) subsidiary to sell AllianceHealth Deaconess hospital in Oklahoma City to INTEGRIS Health's unit.
4 Solid Reasons to Retain Anthem (ANTM) in Your Portfolio
by Zacks Equity Research
Riding high on four factors, Anthem (ANTM) holds great potential to generate high returns for investors.
Molina Healthcare Hits 52 Week High: Is Further Upside Left?
by Zacks Equity Research
Molina Healthcare's (MOH) receipt of Florida Medicaid contract and a clearer visibility on its turnaround initiatives appear to appreciate its stock price.
UnitedHealth's Ratings Upgraded by A.M. Best, Outlook Stable
by Zacks Equity Research
A.M. Best upgrades the ratings of UnitedHealth (UNH) and its subsidiaries. The outlook for the ratings remains stable.
Top Ranked Momentum Stocks to Buy for June 22nd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 22nd: